BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1351259)

  • 1. Efficacy of the 21-aminosteroid U74006F in improving neurological recovery after spinal cord injury in rats.
    Holtz A; Gerdin B
    Neurol Res; 1992 Mar; 14(1):49-52. PubMed ID: 1351259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blocking weight-induced spinal cord injury in rats: therapeutic effect of the 21-aminosteroid U74006F.
    Holtz A; Gerdin B
    J Neurotrauma; 1991; 8(4):239-45. PubMed ID: 1803032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of delayed administration of U74006F (tirilazad mesylate) on recovery of locomotor function after experimental spinal cord injury.
    Anderson DK; Hall ED; Braughler JM; McCall JM; Means ED
    J Neurotrauma; 1991; 8(3):187-92. PubMed ID: 1803027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the 21-aminosteroid U74006F and methylprednisolone on motor function recovery and oedema after spinal cord compression in rats.
    Farooque M; Olsson Y; Holtz A
    Acta Neurol Scand; 1994 Jan; 89(1):36-41. PubMed ID: 8178626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the 21-aminosteroid U74006F on posttraumatic spinal cord ischemia in cats.
    Hall ED
    J Neurosurg; 1988 Mar; 68(3):462-5. PubMed ID: 3343617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between attenuation of posttraumatic spinal cord ischemia and preservation of tissue vitamin E by the 21-aminosteroid U74006F: evidence for an in vivo antioxidant mechanism.
    Hall ED; Yonkers PA; Horan KL; Braughler JM
    J Neurotrauma; 1989; 6(3):169-76. PubMed ID: 2810381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the 21-aminosteroid U74006F on experimental head injury in mice.
    Hall ED; Yonkers PA; McCall JM; Braughler JM
    J Neurosurg; 1988 Mar; 68(3):456-61. PubMed ID: 3343616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of renal reperfusion injury in rats by the 21-aminosteroid U74006F.
    Stanley JJ; Goldblum JR; Frank TS; Zelenock GB; D'Alecy LG
    J Vasc Surg; 1993 Apr; 17(4):685-9. PubMed ID: 8464086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of 21-aminosteroid lipid peroxidation inhibitor, U74006F, in the rat middle cerebral artery occlusion model.
    Umemura K; Wada K; Uematsu T; Mizuno A; Nakashima M
    Eur J Pharmacol; 1994 Jan; 251(1):69-74. PubMed ID: 8137871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the aminosteroid U74006F after cardiopulmonary arrest in dogs.
    Natale JE; Schott RJ; Hall ED; Braughler JM; D'Alecy LG
    Stroke; 1988 Nov; 19(11):1371-8. PubMed ID: 3188122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of the lipid peroxidation inhibitor, U74006F, to prevent postischemic selective neuronal injury.
    Buchan AM; Bruederlin B; Heinicke E; Li H
    J Cereb Blood Flow Metab; 1992 Mar; 12(2):250-6. PubMed ID: 1548297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limiting ischemic spinal cord injury using a free radical scavenger 21-aminosteroid and/or cerebrospinal fluid drainage.
    Francel PC; Long BA; Malik JM; Tribble C; Jane JA; Kron IL
    J Neurosurg; 1993 Nov; 79(5):742-51. PubMed ID: 8410254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic value of 21-aminosteroid U74389F in acute spinal cord injury.
    Haghighi SS; Hall ED; Geng XZ; Oro JJ; Johnson GC
    Neurol Res; 1993 Oct; 15(5):321-6. PubMed ID: 7905606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The novel 21-aminosteroid U74006F attenuates cerebral edema and improves survival after brain injury in the rat.
    McIntosh TK; Thomas M; Smith D; Banbury M
    J Neurotrauma; 1992; 9(1):33-46. PubMed ID: 1619674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 21-aminosteroid tirilazad mesylate can ameliorate inflammatory bowel disease in rats.
    Yue G; Sun FF; Dunn C; Yin K; Wong PY
    J Pharmacol Exp Ther; 1996 Jan; 276(1):265-70. PubMed ID: 8558441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of new 21-aminosteroid tirilazad mesylate (U74006F) on chronic cerebral vasospasm in a "two-hemorrhage" model of beagle dogs.
    Matsui T; Asano T
    Neurosurgery; 1994 Jun; 34(6):1035-9; discussion 1039. PubMed ID: 8084388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a 21-aminosteroid, U74006F, on lipid peroxidation and glomerulotubular function following experimental renal ischemia.
    Shackleton CR; Ettinger SL; Scudamore CH; Toleikis PF; Keown PA
    J Surg Res; 1994 Oct; 57(4):433-7. PubMed ID: 7934019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of combined treatment with melatonin and methylprednisolone on neurological recovery after experimental spinal cord injury.
    Cayli SR; Kocak A; Yilmaz U; Tekiner A; Erbil M; Ozturk C; Batcioglu K; Yologlu S
    Eur Spine J; 2004 Dec; 13(8):724-32. PubMed ID: 15232723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of treatment with U-74006F on neurological outcome following experimental spinal cord injury.
    Anderson DK; Braughler JM; Hall ED; Waters TR; McCall JM; Means ED
    J Neurosurg; 1988 Oct; 69(4):562-7. PubMed ID: 3418389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of a novel nonglucocorticoid 21-aminosteroid (U74006F) during traumatic shock in rats.
    Aoki N; Lefer AM
    J Cardiovasc Pharmacol; 1990 Feb; 15(2):205-10. PubMed ID: 1689414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.